Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

No 9 (2023)

Cover Page

Full Issue

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Reviews

Platelet activation by seminal plasma components in the induction of mechanisms of immunological tolerance in pregnancy

Zhukova A.S., Nikolaeva M.A., Krechetova L.V.

Abstract

The non-hemostatic function of platelets has been confirmed by numerous studies. Besides their participation in pathological processes, these cells play an important role in the menstrual cycle, embryo implantation and maintaining the pregnancy. Megakaryocyte derivatives contribute to leukocyte differentiation, polarization of the immune response and the induction of immunological tolerance through the secretion of soluble mediators and through direct intercellular interactions in the activation process. The activation occurs both in response to changes in hemodynamics and due to the action of factors found in the platelet microenvironment on a wide spectrum of receptors on their surface. The thorough analysis of the composition of seminal plasma revealed a wide range of components that can modulate the functional activity of platelets, namely, induction of migration, aggregation, secretion of granule contents, expression of activation markers, apoptosis. A local short-term inflammation that develops after semen plasma enters the female reproductive tract is able to determine the nature of platelet-leukocyte interactions followed by the recruitment of neutrophil granulocytes in this area, their timely elimination and migration of T-regulatory lymphocytes. Incorrect platelet activation by seminal plasma components can lead to an increase in their procoagulant potential which is associated with impaired vascularization processes, the development of microthrombi in uterine vessels and the progression of placenta-associated pregnancy complications.

Conclusion: Seminal plasma components provide regulation of molecular and cellular interactions including platelet activation involved in the preparation of the female reproductive tract for embryo implantation and the creation of a microenvironment favorable for maintaining the pregnancy.

Obstetrics and Gynecology. 2023;(9):5-11
pages 5-11 views

Factors regulating placental angio/vasculogenesis in complications of pregnancy and childbirth

Khomyakova E.V., Ziganshina M.M., Baev O.R.

Abstract

The normal development and functioning of the placenta can be due to the proper regulation of the vasculogenesis and angiogenesis processes. Factors that regulate vasculogenesis and angiogenesis are the VEGF family and their receptors (VEGFR-1, VEGFR-2 and VEGFR-3). The disbalance of these factors leads to aberrant development of placental vessels which results in pathological disorders of placentation and can be associated with pregnancy complications such as preeclampsia, gestational hypertension, preterm birth, fetal growth retardation, acute fetal hypoxia. Mild placental angiogenesis disorders may not have obvious clinical manifestations, such as those that develop in preeclampsia and fetal growth retardation. However, due to the influence of trigger factors in childbirth, inadequate angiogenesis can lead to decompensation of placental circulation which is clinically manifested as acute fetal hypoxia. This review presents a brief characteristic and description of the main functions of the factors regulating angiogenesis, namely the VEGF family (VEGF-B, VEGF-C, VEGF-D, VEGF-E, VEGF-F, PlGF) and their receptors (VEGFR-1, VEGFR-2 and VEGFR-3), their role in physiological or pathological vasculo-genesis and angiogenesis of the placenta. The changes in angiogenic factors in the maternal blood in normal pregnancy/childbirth and in pathology, as well as in different methods of delivery, are presented. The effect of labor and induction of labor on changes in angiogenic factors is shown and the pathophysiological mechanisms underlying these changes are described. This review presents a modern perspective on the possibilities of predicting complications of pregnancy and childbirth based on monitoring of these factors.

Conclusion: The level of angiogenic factors in the maternal peripheral blood correlates with the morphofunctional state of the placenta. The profile of angiogenic factors is likely to reflect a particular clinical picture of placental insufficiency including a latent form that does not manifest itself during pregnancy but leads to fetal hypoxia during childbirth.

Obstetrics and Gynecology. 2023;(9):12-21
pages 12-21 views

All that practitioners should know about ductus venosus

Yarygina T.A., Gasanova R.M., Marzoeva O.V., Sypchenko E.V., Gus A.I.

Abstract

This article reviews essential information for clinical specialists regarding the ductus venosus, a functionally significant component of the unique fetal circulation system. It outlines the main stages of formation and the normal anatomical structure of the venous system, which plays a crucial role in providing the oxygenation required for the physiological development of the fetus. The article also describes a technique for obtaining ultrasound images of all components of the afferent-venous complex of the placenta, with a focus on the venous duct. It discusses various types of umbilical-portal-systemic venous shunts that can be detected during the prenatal stage and their association with high risks of syndromic pathology and functional disorders in the fetus. These cases necessitate an individualized approach for the examination and management of each clinical scenario. Additionally, this article covers the guidelines and indications for Doppler assessment of blood flow velocity curves in the venous duct for various complications in both singleton and multiple pregnancies. The authors present data on the normal postnatal closure of the ductus venosus and potential manifestations of a persistent open ductus venosus in children, a rare pathology that significantly affects newborns.

Conclusion: Raising awareness among practitioners regarding the importance of perinatal ultrasound diagnosis for ductus venosus pathologies and hemodynamic disorders will enhance the efficiency of medical care, ultimately reducing perinatal and childhood morbidity and mortality.

Obstetrics and Gynecology. 2023;(9):22-32
pages 22-32 views

Teratogenic effect of cytomegalovirus

Lavrukhina M.A., Kasyanova G.V.

Abstract

Congenital cytomegalovirus infection (CMVI) often causes malformations and pathology of fetal organs; its rate ranges from 0.2 to 2.2%. The likelihood of vertical transmission increases as gestation progresses. The severity of the consequences for the newborn is inversely proportional to the gestational age in case of infection. There are three forms: clinical (moderate and severe, mild and isolated hearing loss), subclinical and complications of congenital CMVI. Early infection, primary CMVI in the mother are the conditions that increase the risk of symptoms in newborns. The clinical form of CMVI develops in 10% of cases and leads to more severe fetal pathologies. Since cytomegalovirus has a tropicity for the cells of the nervous and reticuloendothelial systems, it most often causes sensorineural hearing loss, ophthalmological complications, and cerebral pathology. Cytomegalovirus can affect the liver causing jaundice, ascites; gastrointestinal tract causing necrotizing enterocolitis, spontaneous perforation of the intestine, intestinal malrotation; respiratory system causing cytomegalovirus pneumonia, pulmonary hypertension, bronchopulmonary dysplasia, necrotic fibrosing pneumonitis; cardiovascular system. It can lead to a decrease in fetal body weight and length. The long-term consequences of congenital CMVI are autism and mental retardation.

Conclusion: Cytomegalovirus is transmitted to the fetus transplacentally. The severity of the fetal pathology directly depends on the gestational age when the infection occurs: malformations develop if the fetus is infected in the first trimester; target organ pathology occurs in the later period of gestation. Antenatal and postnatal infection leads to the development of CMVI which is not classified as a congenital infection. It causes the damage to internal organs and systems that manifest in the neonatal period.

Obstetrics and Gynecology. 2023;(9):34-42
pages 34-42 views

Shoulder pain syndrome after laparoscopy: epidemiology, pathogenesis, prevention methods

Shapovalova E.A., Basos A.S., Shkarupa I.A., Glushchenko Z.V., Тereshin S.М., Babina U.F., Savina A.A., Shiryaeva A.V.

Abstract

Laparoscopy is considered the gold standard for the surgical treatment of most pelvic diseases. Along with this, laparoscopic interventions are accompanied by the appearance of a specific postlaparoscopic shoulder pain (PLSP). During the first two days after surgery some patients can experience a severe pain which limits their mobilization. There is a global trend towards the introduction of protocols for enhanced recovery after surgery (ERAS) aimed at reducing the stress associated with the surgical intervention and the rapid return of patients to normal life. This article describes the epidemiology of postlaparoscopic shoulder pain. Its pathogenesis and the most common theories of its origin are reviewed. The results of the studies devoted to the methods of reducing postoperative pain syndrome in accordance with the suggested theories are presented in the article. There is a description of the effect of changing the gas for the pneumoperitoneum and reducing its pressure level, instillation of saline solution into the abdominal cavity, forced gas removal, as well as local use of anesthetics.

Conclusion: To date, this issue has not been sufficiently covered in the national literature, and the available data from foreign studies are contradictory. It is necessary to conduct the research on the frequency of postlaparoscopic pain syndrome and factors affecting its severity, as well as the search for effective and safe methods for its reduction.

Obstetrics and Gynecology. 2023;(9):44-51
pages 44-51 views

Postmenopausal osteoporosis

Sulima A.N., Bulyuk V.V., Mitrofanova O.A.

Abstract

The literature review is devoted to the problem of postmenopausal osteoporosis – a systemic, metabolic disease of skeleton characterized by low bone mass and damaged bone microarchitectonics, that often occur in postmenopausal women. Decline in bone mass and changes in its structure lead to increased bone fragility. As a result, mechanical failure of bones begins, which is clinically manifested by fractures. The literature search was conducted using key words “menopause”, “osteoporosis”, «hypoestrogenemia», «T-index», «hormonal therapy» in databases Web of Science, (eLibrary), Scopus, PubMed/MEDLINE. The articles published in 2001–2022 that were devoted to the problem of postmenopausal osteoporosis and its impact on the quality of life of menopausal patients were selected. To prevent missing relevant articles, methodological filters were not used. The study included full-text sources and literature reviews of the topic under study. The articles that were not directly related to the topic of postmenopausal osteoporosis were excluded from the review. To avoid inclusion of duplicate publications in the literature review in cases when two studies by the same authors were identified, the period of study by each author was examined and when the dates of studies coincided, the most recent publication was selected. The article discusses the pathogenetic mechanisms of osteoporosis during menopause. Low estrogen levels in women play a key role, and in turn lead to greater bone resorption than bone formation. Risk factors for the development of osteoporosis – age, sex, ethnic predisposition – were described. The clinical picture of the disease and diagnostic methods are presented in the study. The issues of possibilities of using hormonal therapy for menopausal osteoporosis, as well as other medication-assisted treatment was described.

Conclusion: Timely diagnosis and early start of menopausal hormone therapy are important for effective therapy of menopausal osteoporosis. Alternative methods of treatment should be considered for the patients over 60 years, who have symptoms of menopause for more than 10 years due to late start and ineffectiveness of menopausal hormone therapy.

Obstetrics and Gynecology. 2023;(9):52-59
pages 52-59 views

Original Articles

Clinical and pathogenetic rationale for two-stage prevention of preeclampsia in high-risk women using an insulin sensitizer for preconception preparation

Tezikov Y.V., Lipatov I.S., Zumorina E.M., Azamatov A.R., Tyutyunnik V.L., Kan N.E., Chekalovets A.L., Borisova A.I., Golodnova A.M.

Abstract

Objective: To demonstrate the effectiveness of a two-step approach for the prevention of pre-eclampsia in high-risk women, consisting of pregestational use of the insulin sensitizer metformin (ISM) followed by low-dose acetylsalicylic acid (LDAA) during pregnancy.

Materials and methods: At the preconception stage, women at high risk of preeclampsia were divided into groups according to the prevention method: group 1, 77 patients who received two-stage prophylaxis (ISM at the preconception stage and LDAA during pregnancy); group 2, 75 patients who received LDAA monotherapy at the gestational stage; group 3, 72 patients who received metformin only preconceptionally; and group 4, 73 patients who refused prevention. Thirty women with physiological gestation served as the controls. At 11–14, 18–21, and 30–34 weeks, hormonal-metabolic, pro-inflammatory, and endothelial-hemostasiological patterns were assessed. Based on the primary outcome, the incidence of pre-eclampsia, the size of the effect of the preventive intervention was calculated.

Results: Clinical and laboratory parallels proved the advantage of a two-stage approach to the prevention of preeclampsia: the incidence of preeclampsia in group 1 was 3.8 times lower (RR 0.26 [0.14; 0.49], RRR 73.7% [50.9; 85.9], ARR 36.3% [22.6; 50.1], NNT 3 [2; 4], χ2=21.58, p<0.001), compared with the group without prevention, and with ISM or LDAA alone, only 2.7 (RR 0.37 [0.21; 0.63], RRR 63.4% [36.9; 78.8], ARR 31.3% [16, 8; 45.8], NNT 4 [2; 6], χ2=14.47, p<0.001) and 1.6 times (RR 0.62 [0.41; 0.94], RRR 37.8 % [6.0; 58.8], ARR 18.7% [3.1; 34.2], NNT 6 [3; 32], χ2=4.62, p=0.03), respectively. In group 1, the incidence of severe preeclampsia was reduced by 3.1 and 3.6 times, early preeclampsia by 1.6 and 1.6 times, relative to groups 2 and 3. The effectiveness of the staged approach was confirmed by the influence of preeclampsia prevention methods on the intensity of compensation for insulin resistance and the associated proinflammatory and prothrombogenic patterns, markers of alteration, and remodeling of the vascular endothelium. The lack of effectiveness of the standard use of LDAA is associated with the lack of a periconceptual influence on key events in early pregnancy.

Conclusion: A new strategy for the prevention of preeclampsia is represented by a staged approach that provides a reduction in cardiovascular risk by developing metabolic resistance in women at high risk of preeclampsia from the stage of pregnancy planning and is implemented as a promising, highly effective, pathogenetically substantiated method of prevention aimed at improving obstetric outcomes and stabilizing cardiovascular disease. the vascular continuum later in life.

Obstetrics and Gynecology. 2023;(9):60-71
pages 60-71 views

Urine steroid profile in pregnant women with isthmic-cervical insufficiency and hyperandrogenism

Mokh A.V., Levakov S.A.

Abstract

Objective: To evaluate the features of urine steroid profile and quantification of urinary steroids in pregnant women with isthmic-cervical insufficiency (ICI) and hyperandrogenism (HA).

Materials and methods: A prospective cohort controlled study was conducted from 2014 to 2019 in Maternity hospital No. 1, a branch of the City Clinical Hospital No. 67 named after L.A. Vorokhobov (Moscow). The study included 98 women. The main group consisted of 63 women with ICI. The control group included 35 women without ICI. HA was assessed by determination of the steroid profile and quantification of urinary steroids using high-performance liquid chromatography. Statistical data processing and analysis was performed using Microsoft Excel 2007, Statistica 12.0. Specific characteristics of urine steroid profile in pregnant women with isthmic-cervical insufficiency and hyperandrogenism were evaluated.

Results: The women with ICI, regardless of the presence or absence of HA, were characterized by monomarkers of the steroid profile of urine – higher levels of androsterone (abs.) (p<0.001), total 17-ketosteroids (17-CS) (p=0.02), van de Calseide discriminants (p<0.001), delta-5-pregnandiol (p=0.03), but low levels of 16-alpha-Hydroxy-Et (p<0.001), 16-alpha-Hydroxy-An (p<0.001) and 16-alpha-hydroxy-DHEA (p=0.02); a combination of markers – van de Kalseide discriminant, 16-alpha-Hydroxy-An, allo-Pd, cholesterol and estrone (OR=19.5). In women with ICI associatade with HA are characterized by the markers: higher values of An, abs. (p=0.001), van de Calseide (p=0.002), Et/Ch (p=0.0003) and estrone (p=0.03) discriminants, and lower ones – 11-Keto-Et, abs. (p=0.005) and % of the sum of 17-KS (p=0.001), 16-alpha-Hydroxy-Et (p=0.04). An association between ICI and HA was established (OR=3.48, 95% CI 1.37–8.84). A trend of greater association of GA of ovarian origin with ICI was revealed in comparison with mixed origin (OR=1.62 (95% CI 0.17–15.72).

Conclusion: HA may lead to changes in metabolic processes, that are manifested by urine steroid profile, since urine composition reflects a general metabolic state and contains metabolites. Based on the stratification data, it is possible to identify specific metabolic patterns that indicate an association between GA and the potential risk of developing ICI.

Obstetrics and Gynecology. 2023;(9):72-81
pages 72-81 views

Clinical and anamnestic factors in the prediction and diagnosis of fetal growth restriction

Volochaeva M.V., Kan N.E., Tyutyunnik V.L., Amiraslanov E.Y., Leonova A.A., Soldatova E.E.

Abstract

Objective: To develop a model for predicting and diagnosing fetal growth restriction based on clinical and anamnestic factors and examination data during pregnancy.

Materials and methods: Postnatally, the weight and growth parameters of 473 newborns were assessed according to the INTERGROWTH-21 centile curves, which made it possible to form a study group that included 202 pregnant women with fetal growth restriction. The comparison group included 206 women without fetal growth restriction who delivered at terms corresponding to the terms in the study group. Risk factors, parameters of somatic and gynecological anamnesis, features of the course of pregnancy and delivery, ultrasound and Doppler data, and a comprehensive assessment of the health status of newborns were analyzed. After statistical processing of the parameters, binary logistic regression was used to develop a mathematical model for predicting fetal growth restriction.

Results: The prognostic model based on binary logistic regression, including somatic and gynecological diseases and medical history, had a sensitivity of 55.6% and specificity of 82.3%. When physical examination data during pregnancy, including fetal abdominal circumference as measured by ultrasound, were added, the model had a sensitivity of 96.7% and a specificity of 76.8%.

Conclusion: The models developed using the binary logistic regression method can be proposed for use in practical healthcare to identify risk groups and predict and diagnose fetal growth retardation, which will allow for timely prevention to reduce the incidence of perinatal complications.

Obstetrics and Gynecology. 2023;(9):82-90
pages 82-90 views

Delivery of patients with a uterine scar who have undergone cell technology in a previous caesarean section

Pekarev O.G., Baranov I.I., Pekareva E.O., Silachev D.N., Pozdnyakov I.M.

Abstract

Objective: To determine the likelihood of successful spontaneous delivery in women with myometrial scars who had undergone cell technology, that is, mesenchymal stromal cell derived exosomes (MSCE), during a previous caesarean section.

Materials and methods: Group 1 (study group) included 60 pregnant and parturient women who underwent cell technologies. Group 2 (control group) consisted of 100 pregnant and parturient women without exosomal support. In addition, an intra-natal assessment of the scar condition was performed in 71 parturient women, including 19 and 22 women from groups 1 and 2, respectively. In addition, the condition of the lower uterine segment was evaluated by ultrasound in 30 women without a post-caesarean uterine scar in the control group. A suprapubic arrangement of a RAB6-D volumetric convex transducer with a frequency of 2–8 MHz and an intracavitary IC5-9-D transducer with a frequency of 4–9 MHz from the GE Voluson E8 device (USA) was used. The primary endpoints were the course of pregnancy and childbirth in patients in the study and control groups. Secondary endpoints included the results of repeated deliveries of patients with uterine scars with and without the use of cell technologies, i.e., exosomal support.

Results: No infectious or inflammatory complications were observed in postpartum women who underwent cell technologies, while 6/100 (6 %) patients in group 2 had symptoms of metroendometritis, which required hospitalization and inpatient treatment. Two patients in group 2 (2%) developed lochiometra, as confirmed by ultrasound and office hysteroscopy. The rate of successful vaginal deliveries was 63.6% (14/22) in the group with prior exosomal support, compared to 20.7% (6/29) in the control group.

Conclusion: This study demonstrated the feasibility of using cell technologies, specifically exosomes derived from mesenchymal stromal cells of placental origin, to improve the repair of postoperative myometrial scars and increase the likelihood of safe spontaneous delivery in women with a history of abdominal delivery. This finding suggests the potential of reducing the cesarean section rate in patients with a post-cesarean uterine scar.

Obstetrics and Gynecology. 2023;(9):91-97
pages 91-97 views

Reproductive function in patients with endocrine infertility

Vostrikov V.V., Nazarenko T.А.

Abstract

Objective: To analyze the restoration of reproductive function in endocrine infertility in women living in Altai Krai.

Materials and methods: The study included 1610 women with ovulation disorders out of 9325 who had sought counseling for infertility from April 27, 2001, to December 31, 2020. According to the classifications relevant during the study period, WHO (1973), and NICE (2013), all women were divided into three groups according to the nature of ovulatory dysfunction. The study analyzed gynecological and extragenital pathology among the groups and the influence of the type of ovulatory dysfunction on the choice of treatment strategy. The results of overcoming infertility in patients are presented.

Results: The anovulatory infertility rate in the entire cohort was 19.6%. The clinical differences among the three study groups were clarified. Information is presented on the restoration of the reproductive function of women with impaired ovulation in real clinical practice. The advantages and disadvantages of various management strategies, from expectant to ART, are presented. Algorithms have been developed to improve the efficiency of reproductive function in anovulatory infertility.

Conclusion: The success in the fulfillment of reproductive potential depends on the correct diagnosis of the causes of ovulation disorders and the choice of a rational way to overcome infertility, considering its clinical and pathogenetic forms. It is advisable to use assisted reproductive technologies when other treatments are ineffective or when multiple factors contribute to infertility. In a hypergonadotropic state, ART using donor oocytes is a rational way to overcome infertility.

Obstetrics and Gynecology. 2023;(9):98-106
pages 98-106 views

Effectiveness of donor-recipient ovarian stimulation programs in oocyte donors at different phases of the menstrual cycle

Lapina V.S., Martazanova B.A., Durinyan E.R., Amyan T.S., Korolkova A.I., Gavisova A.A.

Abstract

Objective: To compare the effectiveness of donor-recipient programs for ovarian stimulation of oocyte donors during the follicular and luteal phases of the menstrual cycle.

Materials and methods: The study included 114 women:30 oocyte donors who underwent ovarian stimulation in both the follicular and luteal phases of the menstrual cycle and 84 recipients who underwent embryo transfer in a cryopreserved cycle. Donor oocytes were retrieved in the follicular and luteal phases in 36 and 48 of these recipients, respectively. The embryological parameters and clinical outcomes of the donor-recipient programs in both groups were evaluated.

Results: An analysis of the embryological parameters of the donor-recipient programs showed no difference in the fertilization rates of the donor oocytes received at different phases of the menstrual cycle, nor in the blastulation rates, number of high-quality blastocysts, and number of cryopreserved embryos. The pregnancy rate in recipients in cryopreserved cycles for embryo transfer, clinical pregnancy rate, reproductive loss rate up to 12 weeks, implantation rate, and live birth rate also did not differ significantly when donor oocytes obtained in the follicular and luteal phases of the cycle were used (p>0.05).

Conclusion: Ovarian stimulation of oocyte donors in the luteal phase of the menstrual cycle does not adversely affect embryological parameters and clinical outcomes of donor-recipient programs. In this context, the implementation of ovarian stimulation in the luteal phase of the cycle is important for different groups of patients to optimize the timing and increase the effectiveness of treatment.

Obstetrics and Gynecology. 2023;(9):107-114
pages 107-114 views

The effectiveness of infertility treatment involving transfer of cryopreserved embryos obtained after autologous embryo-cumulus cells co-culture in women with repeated inplantation failure

Asfarova G.R., Smolnikova V.Y., Makarova N.P., Zingerenko B.V., Kalinina E.A.

Abstract

Objective: To evaluate the effectiveness of infertility treatment in the programs of cryo-embryo transfer, when embryos were obtained after autologous co-culture with cumulus cells in assisted reproductive technology (ART) programs.

Materials and methods: 198 married couples with repeated implantation failure (at least 2 attempts) were examined during the period of the study. The couples underwent IVF treatment with frozen-thawed embryo transfer into the uterine cavity. 114 couples underwent the program of autologous embryo-cumulus cells co-culture, and 84 couples underwent IVF treatment with frozen-thawed embryo transfer without using this program. Preparation of all women for cryo-transfer included cyclic hormonal treatment. Only one embryo was thawed and transferred into the uterine cavity. Pregnancy and birth rates were assessed.

Results: The study showed that autologous embryo-cumulus cells co-culture increased pregnancy rate in the group of women aged ≤35 years from 26.3% to 48.2% (OR 1.83; 95% CI 1.00–3.32) and significantly dicreases pregnancy rate in women of later reproductive age from 41.3% to 20.6% (OR 0.37; 95% CI 0.15–0.88). There was no significant difference in birth rates between the groups.

Conclusion: The results obtained in the study make it possible to recommend using autologous embryo-cumulus cells co-culture in women aged ≤35 years, who had repeated failed attempts of ART in history, to improve the effectiveness of infertility treatment.

Obstetrics and Gynecology. 2023;(9):115-120
pages 115-120 views

Clinical and anamnestic features of diseases of the cervix

Levakov S.A., Sheshukova N.A., Obukhova E.A., Dzhafarova M.M., Kaviladze M.G.

Abstract

Objective: Investigation of risk factors for tumor transformation based on the study of clinical and anamnestic features of the course of various pathological processes in the cervix.

Materials and methods: The study included 210 female patients of reproductive age, who were divided into 5 groups: group 1 consisted of 37 women with cytological findings "NILM"+high carcinogenic risk of human papillomavirus (HR HPV); group 2 consisted of 43 women with cytological findings "LSIL"+HR HPV; group 3 consisted of 46 patients with cytological findings "HSIL"+HR HPV; group 4 comprised 39 patients with cytological findings "NILM", hyperkeratosis of squamous epithelium an absence of HPV; group 5 (the comparison group) comprised 45 women with cytological findings "NILM" and the absence of HPV.

Results: The severity of cervical intraepithelial lesions was not associated with the age of patients and the intake of oral contraceptives. The patients with LSIL+HR HPV and HSIL+HR HPV had early sexual debut (the average age of 17 years), (p<0,001). It was found that the severity of intraepithelial lesions and duration of HPV persistence depended on the number of sexual partners (p<0,001). The largest number of smoking patients (51.2% and 41,3%) and women with early sexual debut were in the groups with mild and severe cervical intraepitheliasl lesions in combination with HR HPV (p<0.001). Sexually transmitted infections were significantly more common in women infected with HR HPV. A combination of endometriosis, uterine fibroids, endometrial hyperplasia and benign mammary dysplasia was found in patients with HPV and squamous intraepithelial lesions of the cervix (p<0.001).

Conclusion: Analysis of the anamnestic data and specific features of the clinical cause of pathological processes in the cervix confirmed again the significance of the importance of certain factors in tumor formation and transformation of cervical epithelial cells.

Obstetrics and Gynecology. 2023;(9):122-128
pages 122-128 views

Discussion Article

Retrospective analysis of hyperthermia associated with epidural analgesia and its relationship with labor progression and delivery mode

Podzolkova N.M., Denisova Y.V., Gerasimov A.N., Denisova Т.V.

Abstract

Objective: To investigate the association between hyperthermia during labor and the use of epidural analgesia (EA), identify the risk factors for its occurrence, and analyze the impact of EA on labor progression and delivery methods.

Materials and methods: This study included 1874 delivery records from January 1 to June 31, 2021, at D.D. Pletnev City Clinical Hospital in Moscow. Among these, 956 involved EA, whereas 918 did not use neuraxial anesthesia. The study categorized cases based on temperature elevation (temperature ≥37°C and <37.5°C, indicative of hyperthermia tendency; temperature ≥37.5°C, hyperthermia) and delivery type (vaginal delivery (VD) and cesarean section (CS)). Patients who gave birth with EA and a temperature <37.5°C (877/956) constituted subgroup A, whereas those with a temperature ≥37.5°C (79/956) belonged to subgroup B. A comparative analysis of patient history, one-way correlation analysis, and analysis of variance were conducted to identify factors predisposing patients to hyperthermia.

Results: The analysis revealed a statistically significant association between the use of EA for pain relief during labor and the occurrence of hyperthermia. Specifically, 97.53% (79/81) of hyperthermia cases were recorded in patients who received EA (95% CI:93.31–99.23, p<0.001). Predisposing factors included the duration of labor, interval between anesthetic administration, number of vaginal examinations (all p<0.001), amniotic fluid characteristics (p=0.001), and cervical dilation at the time of analgesia (p=0.002). Hyperthermia in the presence of EA was associated with a higher risk of operative delivery, with emergency CS performed 2.5 times more frequently (30.4% (24/79) vs. 12.2% (107/877), p<0.001) and vacuum-assisted fetal extraction performed 2.9 times more frequently (10.1% (8/79) vs. 3.5% (31/877), p=0.003) in subgroup B than in subgroup A. The most common indication for surgery was fetal distress, (patients with EA and a body temperature of 37.5°C or higher were 2.6 times more likely to have fetal distress than in those without hyperthermia (29.1% (23/79) and 11.4% (100/877), p <0.001).

Conclusion: Early and prolonged EA is associated with an increased risk of hyperthermia, operative delivery, and adverse perinatal outcomes. Optimizing the application of this form of labor pain relief can enhance the quality of obstetric care.

Obstetrics and Gynecology. 2023;(9):129-138
pages 129-138 views

Health Care Management

Staff complement for obstetricians-gynecologists in medical facilities in the Far Eastern Federal District of the Russian Federation in 2017–2021

Stupak M.V., Ivanova M.A., Liutsko V.V.

Abstract

Relevance: The issue of staff complement for doctors in medical faciltites is of high relevance in terms of availability and timeliness of health care delivery. It is extremely important to deliver timely care, including preventive care in obstetrics and gynecology to preserve reproductive health in female population. he timeliness directly influences staff complement for obstetricians and gynecologists in medical facilities.

Objective: To investigate the level of staff complement for obstetricians and gynecologists in medical facilities in the Far Eastern Federal District.

Materials and methods: The analysis of the staffing levels for obstetricians and gynecologists in medical facilities in the Far Eastern Federal District was carried out according to the Federal statistical monitoring data for the period 2017–2021. Descriptive statistics and analytical research methods were used in the study.

Results: Staffing levels for obstetricians and gynecologists in medical facilities in Russia per the number of occupied positions over the past five years generally decreased from 90.2% to 86.2%; in the Far Eastern Federal District from 90.8% to 83.0%, and in the Khabarovsk Territory from 84.5% to 80.0%. This trend is also typical for other Federal Districts, with the exception of the North-Caucasian Federal District, where it increased from 91.4% to 92.5%. Calculations of the number of individuals showed widespread reduction of this indicator both throughout the country and in the Federal Districts was based on calculation of the total number of individuals. At the same time, opposite trends were observed in the territorial subjects of the Far Eastern Federal District.

Conclusion: Over the past five years, staffing levels for obstetricians and gynecologists tended to decrease in all Federal Districts, while in the most territorial subjects of the Far Eastern Federal District, staffing levels for specialists that was calculated per the number of individuals, increased.

Obstetrics and Gynecology. 2023;(9):139-146
pages 139-146 views

Exchange of Experience

Medico-social profile of contemporary medical workers

Bryzgalova O.E., Armashevskaya O.V., Pogonin A.V.

Abstract

Objective: To present a comprehensive medical and social profile of health care professionals working in the field of obstetrics and gynecology in outpatient settings.

Materials and methods: To conduct this study, we developed a comprehensive toolkit comprising both closed- and open-ended questions, addressing various aspects of the daily lives of medical practitioners. A sociological survey was administered to 250 medical professionals specializing in obstetrics and gynecology, delivering outpatient care across nine antenatal clinics affiliated with the S.I. Spasokukotsky City Clinical Hospital. Data analysis, including calculation of extensive indicators, was performed using MS Excel 2016.

Results: Contemporary medical professionals providing outpatient obstetrics and gynecology care were primarily women of working age, residing in separate accommodations, married with children, earning an average income, leading healthy lifestyles, and driven by a genuine vocation for medicine. They demonstrated a patient-centered approach, expressed satisfaction with their professional roles, and recognized the importance of continually enhancing their legal knowledge.

Conclusion: Despite the challenges inherent in the current healthcare system models, particularly within maternal and child health, contemporary medical practitioners harness the advancements and opportunities of their era. Elevating their status within modern society, enhancing the prestige of their profession through media exposure, and cultivating positive public perception are vital incentives for bolstering their professional motivation.

Obstetrics and Gynecology. 2023;(9):147-153
pages 147-153 views

Improving management strategy for patients with polyhydramnios

Dobrokhotova Y.E., Borovkova E.I., Belousova T.N., Burdenko M.V., Kulikov I.A., Vdovichenko E.A., Davydova D.S.

Abstract

Objective: To evaluate the effectiveness of combination therapy in patients with virus-induced polyhydramnios.

Materials and methods: The study included 82 patients with polyhydramnios who had a new coronavirus infection COVID-19. The patients of the main group received combination treatment with indomethacin and immunomodulator Superlymph, the patients of the control group were treated with systemic antibiotics.

Results: The average size of the maximum pocket in the patients of the main group was 12.42 cm at the start of treatment, it decreased to 10.5 cm on the 3rd day and normalized in 19.23% of patients. Amniotic fluid volume was normalized on the 10th day from the start of therapy in 51.92% of patients, mild polyhydramnios persisted in 44.23% of women, moderate polyhydramnios was noted in 3.85% of patients. After two weeks from the start of treatment, amniotic fluid volume was completely normalized in 78.85%, mild polyhydramnios persisted in 15.38%, moderate polyhydramnios was observed in 5.77%. The diagnosis of polyhydramnios was eliminated in 92.31% of the patients after three weeks. The effectiveness of treatment was 60% in the control group. The size of the maximum pocket was 12.57 cm at the start of treatment, it was 10.2 cm on the 7th day; on the 14th day after the end of therapy, mild polyhydramnios persisted in 23.33% of patients and moderate polyhydramnios was noted in 16.67% of patients.

Conclusion: It is possible to prescribe combination therapy with indomethacin and immunomodulator Superlymph for patients with polyhydramnios. The results of the study showed a decrease in amniotic fluid volume according to ultrasound data and they did not affect perinatal outcomes.

Obstetrics and Gynecology. 2023;(9):154-162
pages 154-162 views

Therapeutic equivalence evaluation of bioequivalent and original micronized vaginal progesterone preparations in hormone replacement therapy in women undergoing frozen-thawed embryo transfer

Bashmakova N.V., Khramtsova A.Y., Dzhalilova E.R.

Abstract

There is currently no evidence for the clinical benefits of using bioequivalent micronized progesterone preparation produced in Russia compared to the original preparation for post-transfer support after the frozen-thawed embryo transfer. Therefore, it is important to confirm the therapeutic equivalence of the Russian preparation in the programs of assisted reproductive technologies (ART).

Objective: To perform a comparative analysis of the effectiveness of frozen-thawed embryo transfer programs and pregnancy outcomes in women who took bioequivalent and original micronized vaginal progesterone preparations for the secretory transformation of the endometrium and post-transfer support.

Materials and methods: The study included 93 infertile women who had frozen-thawed own embryo transfer with hormone replacement therapy cycle in the Assisted Reproduction Department, Urals Scientific Research Institute for Maternal and Child Care. The first group consisted of 45 patients who took Russian bioequivalent micronized progesterone preparation “DlyJens pro” (600 mg/day intravaginally) for full secretory transformation of the endometrium, the second group included 48 patients who were prescribed original micronized vaginal progesterone preparation (600 mg/day intravaginally).

Results: The implantation rate was 22/45 (48.89%) patients in group 1, it was 21/48 (43.75%) in group 2. The clinical pregnancy rate was higher in group of patients who took the bioequivalent micronized progesterone preparation than in group 2 and it was 19/45 (42.22%), however, no statistical differences were found (p=0.796). There was no statistical difference in the rate of multiple pregnancies in both groups (p=0.462). Multiple pregnancies were detected in 4/19 (21%) patients in group 1 and in 6/19 (31.6%) patients in group 2.

Conclusion: The data obtained in the study on the outcomes of frozen-thawed embryo transfer programs showed comparable effectiveness of the bioequivalent and original micronized progesterone preparations. The study demonstrated the possibility of using both original and bioequivalent micronized vaginal progesterone preparations in hormone replacement therapy cycles in assisted reproduction.

Obstetrics and Gynecology. 2023;(9):164-169
pages 164-169 views

The effect of myoinositol and D-chiroinositol in a ratio of 40:1 on hormonal and metabolic parameters in women with polycystic ovary syndrome

Pustotina O.A., Rasulova I.A.

Abstract

Background: Insulin resistance (IR) and compensatory hyperinsulinemia are considered to trigger pathogenetic changes in women with polycystic ovary syndrome (PCOS); however, insulin-sensitizing therapy shows contradictory results.

Objective: To evaluate the incidence of metabolic disorders in patients with PCOS and the effect of a combination of myoinositol (MI) and D-chiroinositol (DHI) in a ratio of 40:1 on hormonal and metabolic parameters.

Materials and methods: This was an open prospective study including 34 patients with the classic PCOS phenotype who received 2255 mg of inositol per day for 3 months (MI and DHI in a ratio of 40:1). Serum levels of follicle-stimulating hormone, luteinizing hormone (LH), estradiol, total and free testosterone, sex hormone binding globulin (SHBG), anti-Mullerian hormone, glucose, insulin, HOMA-IR index and body mass index (BMI) were evaluated before and after administration.

Results: The classic PCOS phenotype is associated with a high incidence of metabolic disorders: 55.9% of the examined women were overweight or obese, 50% had IR, 17.6% had a history of gestational diabetes mellitus, 61.8% had a family history of type 2 diabetes mellitus. After 3 months of taking a combination of MI and DHI in a ratio of 40:1, the parameters significantly decreased, namely, BMI (p=0.0029) and IR index (p=0.0007); the number of patients with elevated insulin levels in the blood decreased by 2.4 times. There was an improvement in markers of ovarian steroidogenesis: the serum level of total testosterone decreased (1.51±0.52 vs. 2.02±0.73 nmol/L, p<0.0001), free testosterone reduced (2.0 (1.0; 2.5) vs. 2.9 (1.6; 4.5) pg/ml, p=0.0002) and LH decreased (6.03±2.12 vs. 7.10±2.66 mME/ml, p=0.0058); concentrations of SHBG (69.15±21.66 vs. 40.78±22.66 nmol/L, p<0.0001) and estradiol (190 (150; 316) vs. 148 (111; 286) pmol/L, p=0.0003) increased.

Conclusion: The combined administration of MI and DCI in a ratio of 40:1 improves metabolic and hormonal parameters in patients with the classic PCOS phenotype.

Obstetrics and Gynecology. 2023;(9):170-178
pages 170-178 views

Guidelines for the Practitioner

Group B Streptococcus infection in pregnant women and newborns: clinical case and current state of the problem

Nikitina I.V., Krogh-Jensen O.A., Budina A.Y., Gordeev A.B., Zubkov V.V., Degtyarev D.N., Priputnevich T.V., Lenyushkina A.A.

Abstract

Group B streptococcus (GBS) is a significant cause of neonatal infections, particularly early-onset neonatal sepsis (EONS). This article presents a clinical case of an atypical course of systemic early neonatal infection caused by GBS in a preterm baby born at 36 weeks of gestation. The initial clinical manifestations, including pronounced hyperbilirubinemia and anemia, were more commonly associated with hemolytic disease of the newborn rather than GBS infection. A comprehensive analysis of the patient's course, clinical and laboratory data is provided, along with a comparison to current global findings. The publication also reviews the epidemiology, etiology, and diagnosis of GBS infections in pregnant women and newborns, with a specific focus on screening and timely diagnosis to reduce the severe outcomes associated with GBS infections in newborns.

Conclusion: Implementing prenatal screening measures, in conjunction with rapid microbiology and molecular genetic research methods, enables the prompt verification of premature newborn diagnoses. This approach facilitates the timely initiation of etiopathogenetic therapy and helps prevent the development of disabling complications.

Obstetrics and Gynecology. 2023;(9):180-190
pages 180-190 views

The use of non-hormonal medications for the correction of menopausal disorders: before, instead or together with menopausal hormone therapy

Tabeeva G.I., Smetnik A.A., Ermakova E.I.

Abstract

The cessation of ovarian function is one of the most significant periods for the female organism. The stage of menopausal transition is already marked by vasomotor symptoms (VMS), sleep disorders, psycho-emotional changes, decreased metabolism and vaginal dryness. Menopausal hormone therapy (MHT) is most effective for relieving these symptoms. However, there are groups of women who should consider using alternative methods of their correction. These patients include women who do not want to take MHT, who have absolute contraindications or some relative contraindications to MHT when the expected risks become more significant than the benefits, who experience side effects after taking MHT, who have examination before being prescribed MHT or when they have to stop taking MHT, who have mild menopausal syndrome, who want to reduce the symptoms of hypoestrogenism during the treatment with gonadotropin-releasing hormone agonists. The article also highlights the possibility of using alternative methods of treatment in addition to MHT when the latter is not effective for vasomotor symptoms: during the first weeks of taking MHT; when it is impossible or not desirable to increase the dose of MHT, for example, in case of adverse effects after increasing the dose of MHT; when there are relative contraindications to MHT; when VMS are not completely controlled despite general satisfaction with the dosage of MHT; when the dose of hormones decreases while the woman’s age and duration of postmenopausal period increase.

Conclusion: The analysis of the literature showed that it is possible to consider soy isoflavones as an effective plant-based remedy for these categories of women. A successful combination of soy isoflavones with other plant components, trace elements and vitamins in the form of the supplement Estrovel can also be used to correct the psycho-emotional condition and neurovegetative changes. According to research data, it can prevent metabolic disorders and cardiovascular diseases in women in the postmenopausal period as well as in the phase of menopausal transition.

Obstetrics and Gynecology. 2023;(9):192-198
pages 192-198 views

Clinical Notes

Experience of metroplasty in the second trimester in women with incompetent uterine scar

Sukhanov A.A., Legalova T.V., Obryadov M.A., Dikke G.B., Kukarskaya I.I.

Abstract

Background: The pregnancy rate in patients with incompetent uterine scar (isthmocele) ranges between 1/1800 and 1/2216, which makes up 6.1% of all pregnancies with a history of cesarean section. Isthmocele occurs in 70% of pregnant women who previously underwent uterine surgery and presents a high risk of uterine rupture. Metroplasty during pregnancy is a rare type of medical care that requires profound knowledge and experience in this area.

Case report: The article presents a clinical observation of a 33-year-old patient with a uterine scar in her second pregnancy after having a cesarean section 6 years before. The routine ultrasound examination revealed a 28.0×16.0×40.0 mm isthmocele at 19–20 weeks’ gestation, clinical symptoms were absent. After the patient was hospitalized, metroplasty was performed. The pregnancy was prolonged to 34 weeks due to the administered medications for the prevention of preterm birth. The thickness of the myometrium in the area of the scar was 2.0 mm. When there were complaints indicating the threat of the uterine rupture (pain in the lower abdomen, a decrease in the thickness of the myometrium to 1.8 mm), a cesarean section was performed. A live premature female infant was born weighing 1922 g, 47 cm long, with an Apgar score of 7–8 points. The wound on the uterus was closed with a double-row continuous polyglycolide suture, peritonization was not performed. The postoperative period was uneventful. The patient was discharged on the 3rd day after the operation. After 6 months, the ultrasound examination showed that the endometrium corresponded to the first phase of the cycle, the uterine scar along the anterior wall had no signs of incompetence and was more than 10 mm thick. The child’s development was age-appropriate.

Conclusion: Metroplasty for the incompetent uterine scar is a method of choice that makes possible to prolong a pregnancy and deliver a viable child at the time close to full-term.

Obstetrics and Gynecology. 2023;(9):200-206
pages 200-206 views

Jubilee

To the jubilee of Professor E.N. Baibarina

Obstetrics and Gynecology. 2023;(9):207-207
pages 207-207 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies